GB0209244D0 - Compounds - Google Patents

Compounds

Info

Publication number
GB0209244D0
GB0209244D0 GBGB0209244.3A GB0209244A GB0209244D0 GB 0209244 D0 GB0209244 D0 GB 0209244D0 GB 0209244 A GB0209244 A GB 0209244A GB 0209244 D0 GB0209244 D0 GB 0209244D0
Authority
GB
United Kingdom
Prior art keywords
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB0209244.3A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Glaxo Group Ltd
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Priority to GBGB0209244.3A priority Critical patent/GB0209244D0/en
Publication of GB0209244D0 publication Critical patent/GB0209244D0/en
Priority to PCT/EP2003/004351 priority patent/WO2003091248A1/en
Priority to AU2003224130A priority patent/AU2003224130A1/en
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
GBGB0209244.3A 2002-04-23 2002-04-23 Compounds Ceased GB0209244D0 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
GBGB0209244.3A GB0209244D0 (en) 2002-04-23 2002-04-23 Compounds
PCT/EP2003/004351 WO2003091248A1 (en) 2002-04-23 2003-04-22 Benzoxazinone derivative
AU2003224130A AU2003224130A1 (en) 2002-04-23 2003-04-22 Benzoxazinone derivative

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0209244.3A GB0209244D0 (en) 2002-04-23 2002-04-23 Compounds

Publications (1)

Publication Number Publication Date
GB0209244D0 true GB0209244D0 (en) 2002-06-05

Family

ID=9935339

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB0209244.3A Ceased GB0209244D0 (en) 2002-04-23 2002-04-23 Compounds

Country Status (3)

Country Link
AU (1) AU2003224130A1 (en)
GB (1) GB0209244D0 (en)
WO (1) WO2003091248A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0310851D0 (en) * 2003-05-12 2003-06-18 Glaxo Group Ltd Compounds
US8759342B2 (en) 2006-07-31 2014-06-24 Janssen Pharmaceutica Nv Benzo[1,4]oxazin-3-one, benzo[1,4]thiazin-3-one and quinolin-2-one urotensin II receptor antagonists
ES2379762T3 (en) 2008-08-02 2012-05-03 Janssen Pharmaceutica N.V. Urotensin II receptor antagonists

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU731104B2 (en) * 1996-05-29 2001-03-22 Warner-Lambert Company Benzoxazinone dopamine D4 receptor antagonists
AU2494300A (en) * 1999-01-07 2000-07-24 American Home Products Corporation 3,4-dihydro-2h-benzo(1,4)oxazine derivatives
CZ20031163A3 (en) * 2000-10-26 2004-04-14 Smithkline Beecham P. L. C. Benzoxazinone derivatives, process of their preparation, their use and pharmaceutical composition in which the derivatives are comprised
GB0101577D0 (en) * 2001-01-22 2001-03-07 Smithkline Beecham Plc Compounds

Also Published As

Publication number Publication date
AU2003224130A1 (en) 2003-11-10
WO2003091248A1 (en) 2003-11-06

Similar Documents

Publication Publication Date Title
GB0212785D0 (en) Compounds
GB0209022D0 (en) Compounds
GB0200283D0 (en) Compounds
AU2003216859A8 (en) Amidoacetonitrile compounds
GB0210762D0 (en) Compounds
GB0211418D0 (en) Compounds
GB0207323D0 (en) Compounds
GB0203778D0 (en) Compounds
GB0212399D0 (en) Compounds
GB0213122D0 (en) Compounds
GB0213011D0 (en) Compounds
GB0209244D0 (en) Compounds
AU2003275480A8 (en) Compounds
GB0203811D0 (en) Compounds
GB0206981D0 (en) Compounds
GB0216252D0 (en) Compounds
GB0209030D0 (en) Compounds
GB0204784D0 (en) Compounds
GB0212398D0 (en) Compounds
GB0211133D0 (en) Compounds
GB0211132D0 (en) Compounds
GB0212401D0 (en) Compounds
GB0210513D0 (en) Compounds
GB0209498D0 (en) Compounds
GB0212438D0 (en) Compounds

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)